Clinical Trial Update: Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients [NA]

View source ↗

Summary

Magenta Medical reports the Magenta Elevate device is in a first-in-human clinical study for high-risk percutaneous coronary intervention, with the trial curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Magenta Elevate

Snippet

Sponsor: Magenta Medical Ltd. | Conditions: High-Risk Percutaneous Coronary Intervention | NA | Status: ACTIVE_NOT_RECRUITING